?Emergent BioSolutions (EBS) Receives a New Order from US Department of War [Yahoo! Finance]
New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading [The New York Times]
Former biotech CEO sued over COVID vaccine alleged insider trading [Yahoo! Finance]
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation